SCHEMBL7610253

SCHEMBL7610253

C=C(NS(=O)(=O)c1ccc2ccccc2c1)NS(=O)(=O)c1ccc2ccccc2c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.61
F2 P00734 2/20 0.55
PRSS1 P07477 2/20 0.55
PRSS2 P07478 2/20 0.55
PRSS3 P35030 2/20 0.55
KAT6A Q92794 3/20 0.53
MEN1 O00255 1/20 0.53
KMT2A Q03164 1/20 0.53
LARS1 Q9P2J5 1/20 0.52
LMNA P02545 4/20 0.52
ATM Q13315 1/20 0.51
CYP19A1 P11511 1/20 0.51
ALDH1A1 P00352 2/20 0.50
RAPGEF3 O95398 1/20 0.50
GAA P10253 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
NLRP3 Q96P20 1/20 0.49
SLC1A3 P43003 1/20 0.49
SLC1A2 P43004 1/20 0.49
SLC1A1 P43005 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11032473 0.84 L3MBTL1 (0.62) L3MBTL1F2PRSS1PRSS2PRSS3
SCHEMBL14607535 0.82 L3MBTL1 (0.57) L3MBTL1F2PRSS1PRSS2PRSS3
SCHEMBL7774671 0.82 L3MBTL1 (0.61) L3MBTL1F2PRSS1PRSS2PRSS3
SCHEMBL3267159 0.81 L3MBTL1 (0.59) L3MBTL1F2PRSS1PRSS2PRSS3
SCHEMBL11162145 0.81 L3MBTL1 (0.64) L3MBTL1F2PRSS1PRSS2PRSS3
SCHEMBL29492938 0.81 L3MBTL1 (0.64) L3MBTL1F2PRSS1PRSS2PRSS3
SCHEMBL3267161 0.81 F2 (0.62) L3MBTL1F2PRSS1PRSS2PRSS3
SCHEMBL14607474 0.80 L3MBTL1 (0.54) L3MBTL1F2PRSS1PRSS2PRSS3
SCHEMBL27854852 0.79 L3MBTL1 (0.67) L3MBTL1F2PRSS1PRSS2PRSS3
SCHEMBL12190353 0.79 L3MBTL1 (0.67) L3MBTL1F2PRSS1PRSS2PRSS3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020198254-A1 Polyamide analogs GENELABS TECHNOLOGIES, INC. 2002-12-26 US claimed
US-20020198254-A1 Polyamide analogs GENELABS TECHNOLOGIES, INC. 2002-12-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020198254-A1 Polyamide analogs CYP51A1, HDAC6, ERG28 L3MBTL1 4011/4885F2 3809/4885PRSS1 1296/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.